The entire wiki reimagined as a visual magazine with video discovery · Watch your interests come alive
The entire wiki reimagined as a visual magazine with video discovery · Watch your interests come alive
Micrograph showing a PD-L1 positive non-small cell lung carcinoma. PD-L1 immunostain
Micrograph showing a PD-L1 positive non-small cell lung carcinoma. PD-L1 immunostain
Pembrolizumab (Pembro) use for treatment of lung cancer in the first line with or without chemotherapy (Chemo). Median overall survival in months (M).
Pembrolizumab (Pembro) use for treatment of lung cancer in the first line with or without chemotherapy (Chemo). Median overall survival in months (M). Hazard Ratio (HR).
Micrograph showing a PD-L1 positive lung adenocarcinoma. Positive immunostaining can predict response to the treatment.
Micrograph showing a PD-L1 positive lung adenocarcinoma. Positive immunostaining can predict response to the treatment.